Clinical Trial Update: Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 Tositumomab [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports Phase 1/Phase 2 results for untreated or transformed follicular lymphoma treated with I-131 labeled tositumomab, and the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• I-131 tositumomab (tositumomab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Non-Hodgkin's Lymphoma | Phase 1, Phase 2 | Status: COMPLETED